丁吡考胺
外观
丁吡考胺 | |
---|---|
![]() | |
IUPAC名 5-Butylpyridine-2-carboxamide | |
别名 | Sch-10595; Fusaramide[1] |
识别 | |
CAS号 | 22632-06-0 ![]() |
PubChem | 31447 |
ChemSpider | 29167 |
SMILES |
|
InChI |
|
InChIKey | VKSPIPWLHGKJQO-UHFFFAOYAT |
性质 | |
化学式 | C10H14N2O |
摩尔质量 | 178.23 g·mol−1 |
若非注明,所有数据均出自标准状态(25 ℃,100 kPa)下。 |
丁吡考胺(英語:Bupicomide,化学名:5-丁基吡啶-2-酰胺,5-Butylpyridine-2-carboxamide)是一种有机化合物,化学式C10H12N2O,具有β受体阻滞剂功能,在临床上用于血管舒張。[2][3][4]
参考文献
[编辑]- ^ Bupicomide (页面存档备份,存于互联网档案馆), Chemical Book
- ^ Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED. Systemic and renal hemodynamic effects of bupicomide: A new vasodilator. American Heart Journal. 1976, 92 (3): 335–9. PMID 782220. doi:10.1016/s0002-8703(76)80114-7.
- ^ Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine. Clinical Pharmacology and Therapeutics. 1975, 18 (2): 145–53. PMID 1097150. S2CID 19966617. doi:10.1002/cpt1975182145.
- ^ Velasco, M.; McNay, J. L. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.. Mayo Clinic Proceedings. 1977, 52 (7): 430–2. PMID 875465.